NEW YORK, NY -- (MARKET WIRE) -- December 21, 2006 -- Daxor Corporation (AMEX: DXR), a medical instrumentation and biotechnology company, today announced the promotions of Stephen Feldschuh to Chief Operating Officer (COO) and David Frankel to Chief Financial Officer (CFO). Stephen Feldschuh was the CFO and VP of Operations and will assume the newly created position of COO. Stephen worked for Daxor from 1992 to 1997 in various roles in operations. He left the Company to earn his MBA in Finance. He worked for two public companies before returning to Daxor in 2001. In 2003 he was promoted to CFO and VP of Operations. Stephen has been responsible for a major change in the organization and the structure of the Company with respect to significant improvements to the BVA-100 distribution, manufacturing and product development. In his new position, Stephen will be focusing on the macro view and driving to achieve the long range goals for Daxor.
